Market Tracker

11/28 6:05pm ET

Actavis PLC (NYSE:ACT)

During the Trading Day
270.61 +0.14 / +0.05%
Data as of 1:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
269.45 -1.16 / -0.43%
 
Volume: 29.2K

Today’s Trading

Previous close270.47
Today’s open270.70
Day’s range269.64 - 272.29
Volume1,175,425
Average volume (3 months)2,918,101
Market cap$71.7B
Dividend yield--
Data as of 1:01pm ET, 11/28/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+42.63%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.94

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.80+1.19%
ABTAbbott Laboratories+0.26+0.59%
AGNAllergan-0.11-0.05%
CELGCelgene+1.08+0.96%
Data as of 1:06pm ET, 11/28/2014

Financials

Next reporting dateFebruary 17, 2015
EPS forecast (this quarter)$3.50
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts